Hyperoxia resulted in increased nuclear staining for SMAD3, along with increased -SMA staining, indicating hyperoxia-induced TGF- activation. specific markers of alveolar development (surfactant proteins A and B, cholinephosphate cytidylyltransferase-, leptin receptor, triglyceride uptake, and [3H]choline incorporation into saturated phosphatidylcholine) and injury/repair, in particular, the markers of transforming growth element- signaling (activin receptor-like kinase-5, SMAD3, lymphoid enhancer element-1, fibronectin, and calponin). Overall, antenatal RGZ accelerated lung maturation and clogged the inhibition of alveolar sacculation and septal wall thinning by hyperoxia. RGZ specifically stimulated the development of the alveolar epithelial type II cell, the lipofibroblast, and the vasculature. The increased expression of the transforming growth element- intermediates, such as SMAD3 and lymphoid enhancer element-1, implicated in hyperoxic lung injury, was also clogged by antenatal RGZ treatment. In conclusion, PPAR- agonists Armillarisin A can enhance fetal lung maturation and may efficiently prevent hyperoxia-induced neonatal lung injury. Keywords:lung development, peroxisome proliferator-activated receptor-, surfactant, lipofibroblast, hyperoxia a number of lines of evidencesuggest that lipids are cytoprotective against o2 totally free radical lung injury in vitro and in vivo (5,23,37). Investigators have suggested that the greater o2 tolerance of newborn rats and mice, compared with Armillarisin A their adult counterparts, relates, in part, to the greater amount of triglyceride in the lipid portion of the newborn compared with the adult lung (14,24,25,37). Feeding pregnant rats a high triglyceride diet results in increased triglyceride content in the lungs Armillarisin A of their offspring, increased survival, and improved pathological status after prolonged hyperoxic publicity (25). In contrast, newborn offspring of rats fed low-polyunsaturated fatty acid diets are more susceptible to pulmonary o2 toxicity and early lethality in hyperoxia (24). Furthermore, Kehrer and Autor (14) exhibited that increasing the saturated fatty acid composition of lung triglycerides in adult rats by dietary manipulation produced increased susceptibility to o2 toxicity. Our laboratory has shown that triglycerides from your circulation are stored in lipofibroblasts, and that this biological lipid compartment shields the lung against oxidant injury (26,34). The trafficking of natural lipid from your circulation is definitely mediated from the lipofibroblast phenotype (34), which is determined by the manifestation of peroxisome proliferator-activated receptor- (PPAR-), which plays a critical part in normal lung development and injury/repair (30,35). Our Armillarisin A laboratory has recently demonstrated that administration of PPAR- agonist rosiglitazone (RGZ) postnatally enhances lung maturation and may prevent hyperoxia-induced neonatal lung injury, suggesting the potential therapeutic usefulness of PPAR- agonists in avoiding and/or treating bronchopulmonary dysplasia (4,20,36). However, it is not known whether administration of PPAR- agonists antenatally could prevent neonatal lung injury. Here, our objective was to determine the effects of antenatal administration of RGZ on fetal lung maturation and on subsequent hyperoxia-induced neonatal lung injury. We hypothesized that antenatal administration of the PPAR- Armillarisin A agonist RGZ would enhance fetal lung maturation and prevent hyperoxia-induced neonatal lung injury. == METHODS == == == == Animals. == Pathogen-free, time-mated Sprague-Dawley rat dams (250300 g body wt) were from Charles River Laboratories (Hollister, CA). For determining whether antenatal RGZ (Cayman Chemical) administration would enhance fetal lung maturation, pregnant dams were administered either diluent or RGZ (3 mg/kg ip) in 100-l quantities, once at embryonic day time (e) 18 (e0 = day time of mating) and 24 h later on once more at e19. For parenteral administration, RGZ was initially dissolved in dimethyl sulfoxide (100 g/l stock solution), and then the required injectable amount was dissolved in cottonseed oil (Sigma-Aldrich, St. Louis, MO; catalog no. C7767). At e20, pups were delivered by cesarean section, and the lungs were examined for markers of lung maturation. For determining the protective effect of antenatal RGZ administration against hyperoxia-induced lung injury postnatally, pregnant dams were administered either diluent or RGZ (3 mg/kg ip) in 100-l quantities, at e21 (term e22). The dose of RGZ used is based on the previous work showing that, when administered in a dose of 3 mg/kg, it accelerates lung maturation and prevents hyperoxia-induced lung injury in neonatal rats (4,18,36). After spontaneous delivery, on postnatalday 1, the pups were placed in either 21 or 95% O2for 24 h, following which their lungs were collected to examine specific markers of lung injury and repair. All animal methods were performed following National Institutes of Health recommendations for the Rabbit polyclonal to APBA1 care and use of laboratory animals, and approved by the Los Angeles Biomedical Research Institute Animal Care and Use Committee. == Lung fibroblast culture. == To elaborate on the mechanism of the effects of hyperoxia on lung injury and how it is mediated by RGZ, e20 fetal rat lung fibroblasts were cultured according to previously explained methods (20). At 80% confluence, cells were pretreated for 1 h with either transforming growth factor (TGF)-1, -2, or -3 antibody (10 M, R&D System, Minneapolis, MN) or RGZ (10 M, St. Louis, MO). The cells.
Hyperoxia resulted in increased nuclear staining for SMAD3, along with increased -SMA staining, indicating hyperoxia-induced TGF- activation